A clinical study of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in preventing neutropenia during concurrent chemoradiotherapy of cervical cancer

PURPOSE: To evaluate the effectiveness and safety of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in preventing neutropenia during chemoradiotherapy in patients with cervical cancer. METHODS: From August 2018 to April 2020, 60 patients who were pathologically confi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Dongling, Guo, Mingfang, Zhou, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173964/
https://www.ncbi.nlm.nih.gov/pubmed/34078317
http://dx.doi.org/10.1186/s12885-021-08364-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173964/
https://www.ncbi.nlm.nih.gov/pubmed/34078317
http://dx.doi.org/10.1186/s12885-021-08364-9

Ejemplares similares